BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26655291)

  • 1. Apolipoprotein A-I interactions with insulin secretion and production.
    Rye KA; Barter PJ; Cochran BJ
    Curr Opin Lipidol; 2016 Feb; 27(1):8-13. PubMed ID: 26655291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism.
    Cochran BJ; Bisoendial RJ; Hou L; Glaros EN; Rossy J; Thomas SR; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2261-7. PubMed ID: 25147338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion.
    Fryirs MA; Barter PJ; Appavoo M; Tuch BE; Tabet F; Heather AK; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1642-8. PubMed ID: 20466975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I primes beta cells to increase glucose stimulated insulin secretion.
    Nilsson O; Del Giudice R; Nagao M; Grönberg C; Eliasson L; Lagerstedt JO
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165613. PubMed ID: 31765698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoA-I and Diabetes.
    King TW; Cochran BJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1362-1368. PubMed ID: 37381981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion.
    Mancuso E; Mannino GC; Fuoco A; Leo A; Citraro R; Averta C; Spiga R; Russo E; De Sarro G; Andreozzi F; Sesti G
    Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2941-2952. PubMed ID: 33086869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
    Gromada J; Brock B; Schmitz O; Rorsman P
    Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I.
    Yamato K; Tamasawa N; Murakami H; Matsui J; Tanabe J; Suda T; Yasujima M
    Diabetes Res Clin Pract; 2005 Aug; 69(2):124-8. PubMed ID: 16005361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
    Vahl T; D'Alessio D
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
    Yabe D; Seino Y
    Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL and Diabetes.
    Cochran BJ; Manandhar B; Rye KA
    Adv Exp Med Biol; 2022; 1377():119-127. PubMed ID: 35575925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells.
    Rütti S; Ehses JA; Sibler RA; Prazak R; Rohrer L; Georgopoulos S; Meier DT; Niclauss N; Berney T; Donath MY; von Eckardstein A
    Endocrinology; 2009 Oct; 150(10):4521-30. PubMed ID: 19628574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism.
    Domingo-Espín J; Nilsson O; Bernfur K; Del Giudice R; Lagerstedt JO
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2822-2834. PubMed ID: 29802959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
    Wang X; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages.
    Tabet F; Lambert G; Cuesta Torres LF; Hou L; Sotirchos I; Touyz RM; Jenkins AJ; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1192-200. PubMed ID: 21330603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Density Lipoproteins and Apolipoprotein A1.
    van der Vorst EPC
    Subcell Biochem; 2020; 94():399-420. PubMed ID: 32189309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
    Ma X; Guan Y; Hua X
    J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoprotein A-I stimulates secretion of insulin and matrix metalloproteinases by islets of Langerhans].
    Usynin IF; Poteryaeva ON; Russkikh GS; Zubova AV; Boiko KY; Polyakov LM
    Biomed Khim; 2018 Mar; 64(2):195-200. PubMed ID: 29723150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
    Pathak V; Vasu S; Flatt PR; Irwin N
    Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.